Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Subhash Bodhankar
Total Records ( 2 ) for Subhash Bodhankar
  K. Yamini Saraswathi , Amol Muthal , Amit Kandhare , Supada Rojatkar and Subhash Bodhankar
  Background: Various anabolic steroids are used to improve endurance and muscle strength. The use of such synthetic drugs is banned by World Anti-Doping Agency due to their adverse and toxic effects. On the other hand, traditional Indian medicinal plants were used by the athletes to improve their endurance and muscle strength. The objective of this study was to evaluate the effect of methanolic extract of Artemisia pallens Wall on endurance of laboratory animals. Materials and methods: Endurance in male Wistar rats (150-180 g) was achieved by treadmill running exercise. The animals were trained for two weeks. The Methanolic Extract of Artemisia pallens Wall (MEAP) was administered orally to the animals for the next 6 weeks and parameters such as CKMB, BUN, serum creatinine, serum glucose, testosterone, total protein, complete lipid profile, heart weight to body weight ratio, electrocardiographic and hemodynamic were evaluated. Lung histopathological assessments were performed. Results: Eight weeks administration of MEAP (100 and 200 mg kg-1) significantly (p<0.05) lowered the serum cholesterol and HDL levels, whereas the serum LDL and triglyceride levels were increased significantly (p<0.05). There was significant (p<0.05) decrease in serum CKMB and creatinine by MEAP (100 and 200 mg kg-1) treatment. MEAP (100 and 200 mg kg-1) was significantly (p<0.05) inhibited breakdown of protein to urea. The electrocardiographic changes like prolongation in QT and QTc intervals were seen with the MEAP (100, 200 and 400 mg kg-1) treatment. Histological aberrations were also ameliorated by MEAP treatment. Conclusion: MEAP (200 mg kg-1) significantly improved the endurance and performance of the animals.
  Sumit Chaudhary , Aakanksha Dube , Prasad Thakurdesai , Subhash Bodhankar and Poonam Piplani
  Background: The purpose of the current study was to investigate the various pharmacological characteristics of a newly synthesized PP-17 [3-(2-hydroxy-3-isopropylamino-propoxy)-benzaldehyde oxime] under the in vitro and in vivo conditions. Methods: Potency of PP-17 was investigated towards different α, β-adrenoceptor subtypes by using rat isolated right atria, uterus, distal colon, thoracic aorta preparations. Antihypertensive and metabolic activity was tested in left renal artery ligated and fructose induced hypertension model. Results: pA2 values of PP-17 for β1, β2, β3 and α1 adrenoceptor were 7.0±0.1, 5.7±0.1, 6.0±0.1 and 7.0±0.1, respectively. The β12 selectivity ratio was calculated and shows in the order of atenolol >PP-17 >labetalol >propranolol while β11 selectivity ratio was in the order of labetalol >PP-17. PP-17 (10 and 30 mg kg-1, p.o.) significantly decreased the mean arterial blood pressure and heart rate in both left renal artery ligated and fructose induced hypertension model. In addition, treatment with PP-17 (30 mg kg-1, p.o.) showed significant decrease in plasma TG and VLDL level. Conclusion: Our results suggest that PP-17 is a dual α1 and β1-adrenoceptor receptor antagonist having antihypertensive property.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility